MarketPeel
Insider Trading Intelligence
EF

Ezra M. Friedberg

PTHS
DIRECTOR · PELTHOS THERAPEUTICS INC. · CIK 0001679440
FILING MIX · LIFETIME44%/56%
BUYS
8
SELLS
10
TOTAL VALUE
$703.6K
COMPANIES
1
ACTIVE SINCE
Jun 2024
HOLDINGS NOW
81,659
AVG SELL PX
$27.63
TRADE KIND
SHOWING 18 / 18
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
7 backtested trades · 8 horizons · 15 pendingHow are these numbers computed? →
Forward-return performance of every backtestable P/S trade by Ezra M. Friedberg, measured at 8 horizons from 7 days to 2 years. Deduped per economic event so co-filings count once. Excess return = trade return minus SPY return over the same window.
HORIZONTRADESWIN RATEINSIDER RETURNSPY RETURNMEAN EXCESSMEDIAN EXCESST-STAT
7d7+71.43%+5.65%+1.66%+3.99%-8.23%
14d7+71.43%+7.94%+2.78%+5.16%-7.79%
30d7+71.43%+13.25%+4.46%+8.79%-4.53%
60d7+71.43%+14.27%+2.57%+5.50%-10.81%
90d7+71.43%+23.86%+5.65%+18.21%-11.04%
180d7(2 pending)+100.00%+20.27%+11.37%+90.12%+90.12%
1y7(6 pending)+100.00%+115.04%+20.91%+94.13%+94.13%
2y7(7 pending)
How to read this: Insider Returnis the average raw return of the filer's trades over the horizon. SPY Return is what SPY did over those same windows — reference only, not a comparison. The headline alpha number is Mean Excess = Insider − SPY; green means the filer beat SPY, red means they trailed it. Win rate is the share of individual trades where the filer beat SPY. T-statvalues above 2 mean the alpha is unlikely to be chance given the sample size. "Pending" counts trades where the horizon hasn't elapsed yet; their stats are not included in the row average.
Holdings over time
PTHS · 81,659 shares · as of Jun 15, 2026
020,64641,29361,93982,58520252026SHARES HELD
Trading cadence · quarterly flow
BUY SELL
2024
2024
2024
2025
2025
2025
2025
2026
2026
FLOW · 8 buys / 10 sellsCOVERAGE · 9 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILEDDETAILS
PTHS
PELTHOS THERAPEUTICS INC.
SALE10b5-1
10b5-1 plan
224$27.12$6.1K81,659Jun 15, 2026Jun 17, 2026View →
PTHS
PELTHOS THERAPEUTICS INC.
SALE10b5-1
10b5-1 plan
59$27.94$1.6K81,600Jun 15, 2026Jun 17, 2026View →
PTHS
PELTHOS THERAPEUTICS INC.
SALE
144$27.01$3.9K81,883May 14, 2026May 18, 2026View →
PTHS
PELTHOS THERAPEUTICS INC.
SALE10b5-1
10b5-1 plan
265$21.36$5.7K82,027Apr 2, 2026Apr 6, 2026View →
PTHS
PELTHOS THERAPEUTICS INC.
SALE10b5-1
10b5-1 plan
293$20.51$6.0K82,292Apr 2, 2026Apr 6, 2026View →
PTHS
PELTHOS THERAPEUTICS INC.
SALE
2,000$28.14$56.3K32,001Nov 25, 2025Nov 26, 2025View →
PTHS
PELTHOS THERAPEUTICS INC.
SALE
5,999$28.00$168.0K34,001Nov 25, 2025Nov 26, 2025View →
PTHS
PELTHOS THERAPEUTICS INC.
SALE
2,000$28.01$56.0K30,000Nov 25, 2025Nov 26, 2025View →
PTHS
PELTHOS THERAPEUTICS INC.
SALE
1$28.50$2932,000Nov 25, 2025Nov 26, 2025View →
PTHS
PELTHOS THERAPEUTICS INC.
PURCHASEGRANT
Stock grant
58,23058,230Jul 2, 2025Jul 7, 2025View →
PTHS
PELTHOS THERAPEUTICS INC.
PURCHASEGRANT
Stock grant
19,10828,012Jul 2, 2025Jul 7, 2025View →
PTHS
PELTHOS THERAPEUTICS INC.
PURCHASEGRANT
Stock grant
19,10882,585Jul 2, 2025Apr 1, 2026View →
PTHS
PELTHOS THERAPEUTICS INC.
PURCHASE
40,00040,000Jul 1, 2025Jul 3, 2025View →
PTHS
PELTHOS THERAPEUTICS INC.
PURCHASE
40,000$10.00$400.0K40,000Jul 1, 2025Jul 3, 2025View →
PTHS
PELTHOS THERAPEUTICS INC.
SALE
40,0000Jul 1, 2025Jul 3, 2025View →
PTHS
PELTHOS THERAPEUTICS INC.
PURCHASE
40,00040,000Jul 1, 2025Jul 3, 2025View →
PTHS
PELTHOS THERAPEUTICS INC.
PURCHASEGRANT
Stock grant
2,45463,477Nov 13, 2024Apr 1, 2026View →
PTHS
PELTHOS THERAPEUTICS INC.
PURCHASEGRANT
Stock grant
6,45061,023Jun 14, 2024Apr 1, 2026View →
Other insiders · PTHS
Loading peer insiders…
About this filer
CIK 0001679440
ROLE
Director
PRIMARY
PTHS
COMPANIES
1
ACTIVE SINCE
Jun 2024
MARKETPEEL · /INSIDER/0001679440DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback